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Diet-derived advanced glycation end products (AGEs)
contribute significantly to accumulation of AGEs in renal
insufficiency. To test whether modulation of dietary AGEs
would impact on progression of chronic renal disease, 5/6
nephrectomy rats were randomly placed on three diets that
differed only in AGEs content (low AGEs diet (LAD), high
AGEs diet (HAD), and standard rodent diet (SRD)) for 5–13
weeks. Compared with SRD- or HAD-fed rats, LAD-treated
animals showed decreased proteinuria and retarded decline
of creatinine clearance without alteration of blood pressure.
Glomerular volume was reduced by 23% compared with
HAD-fed rats at week 13 (Po0.001). Renal fibrosis progressed
with time in the remnant kidneys from HAD-fed rats.
However, LAD-fed animals presented a better-preserved
structure of the kidneys. LAD-fed rats demonstrated
significantly decreased serum and renal AGEs concentration
(Po0.01 and Po0.01). This was associated with marked
decrease of intrarenal advanced oxidation protein products
and thiobarbituric acid reactive substances, as well as
increase of glutathione peroxidase activity. LAD treatment
also downregulated expression of monocyte
chemoattractant protein-1 and transforming growth
factor-b1 and ameliorated macrophage infiltration in the
remnant kidney. These results demonstrated that restriction
of dietary AGEs intake retards progression of renal fibrosis
and dysfunction in the remnant kidney model.
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Chronic kidney disease (CKD) is a significant interactive
disease in patients with diabetes, hypertension, and cardio-
vascular disease with major morbidity consequences and high
costs to the healthcare system.1 Renal fibrosis, the final
common pathway of CKD, predicts the degree of renal
dysfunction and long-term prognosis for almost all forms of
CKD.
Numerous mechanisms have been implicated in the
initiation of this cascade including activation of renin-angio-
tensin system, overexpression of cytokines, redox imbalance,
and metabolic toxins accumulation.2 Advanced glycation end
products (AGEs) might be one of these toxins. Endogenous
AGEs are formed during nonenzymatic reaction between
protein and glucose or glucose degradation products under
hyperglycemia.3,4
Increased AGEs burden has also been demonstrated in
euglycemic patients with renal insufficiency, in whom AGEs
accumulation is attributed to either decreased renal clearance
or increased formation of these compounds owing to
enhanced oxidative stress.5,6
In addition to those endogenously formed, AGEs are
abundant in exogenous sources such as foods, especially
when prepared under elevated temperature.7 Modulation of
dietary AGEs in human subjects or animals with or without
diabetes or renal disease modifies circulating AGEs levels,
suggesting that dietary AGEs intake constitutes an important
source of the body AGEs pool.8,9
It has been documented that AGEs, both endogenously
formed and exogenously ingested, are bioreactive toxins8,10,11
and contribute to the complications of diabetes and renal
insufficiency, such as endothelial dysfunction, accelerated
atherosclerosis, and b2-microglobulin amyloidosis.10–12 Pro-
longed intravenous injection of pre-formed AGEs into
normal animals results in albuminuria and glomerular
sclerosis,13 suggesting that AGEs might be a class of renal
fibrogenic factors.
Kidney is the major organ for dealing with the daily
load of dietary AGEs7,14 and the predominant tissue of
AGEs accumulation after oral administration.15 Plasma
AGEs levels are closely correlated with the progression
of renal insufficiency.16 Thus, it is important to clarify
whether accumulating dietary AGEs contribute significantly
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to the progression of CKD, especially in the presence of
renal insufficiency. A short-term in vivo animal study has in
part revealed this pathogenic link by showing that the
administration of an AGEs-rich diet to the remnant kidney
model for a short period (6 weeks) result in increase of
proteinuria.17 However, the impact of prolonged load of
dietary AGEs on the structure and function of the kidney,
particularly in the presence of renal dysfunction, has
remained unclear.
This study was conducted to test the hypothesis that
modulation of dietary AGEs intake may modify progression
of CKD.
RESULTS
Effects of dietary AGEs on serum and renal AGEs levels
As shown in Table 1, the three kinds of diet were nutritionally
equivalent and differed only in AGEs content. As the daily
food intake was equal between high AGEs diet (HAD)-, low
AGEs diet (LAD)- and standard rodent diet (SRD)-fed
groups (Figure 1a), HAD-fed animals ingested threefold
more AGEs and LAD-fed rats ingested onefold less AGEs as
compared with SRD-fed animals.
Serum AGEs levels, assessed as Ne-carboxymethyllysine
(CML)-like immunoepitopes, were significant higher in 5/6
nephrectomy (5/6 Nx) rats than the sham-operated controls
(Po0.05). Animals given HAD showed marked increase of
serum AGEs as compared with SRD-fed 5/6 Nx rats. LAD-
treated rats had significant lower serum AGEs levels than
SRD-fed 5/6 Nx animals (Figure 1b). A similar pattern was
observed in AGEs levels in the remnant kidney among
animals received three kinds of diet (Figure 1c). There was no
significant difference in lipid profile and albumin levels
among 5/6 Nx rats given food containing different levels of
AGEs (Table 2).
Effect of dietary AGEs on renal compensatory growth
As shown in Table 3, the weight of the remnant kidney
increased with time in 5/6 Nx rats as compared with sham-
operated controls. The increment, expressed as the left kidney
weight/body weight, was significant higher in the HAD-fed
Table 1 | Characteristic of the dieta
HAD LAD SRD
Nutrients
Protein (g/100 g) 17.5 17.0 16.0
Fat (g/100 g) 6.3 6.1 5.0
Carbohydrate (g/100 g) 61.0 60.0 65.0
Fiber (g/100 g) 2.5 2.6 2.4
Calcium (g/100 g) 1.3 1.3 1.2
Phosphate (g/100 g) 0.4 0.5 0.4
Soluble chloride (g/100 g) 0.3 0.4 0.4
Lysine (g/100 g) 0.8 0.8 0.7
Methionine (g/100 g) 0.4 0.4 0.4
Vitamin A (IU/100 g) 253 240 238
Vitamin D3 (IU/100 g) 130 120 110
Vitamin E (IU/100 g) 5.5 5.6 5.0
Total calories (kcal/g) 3.5 3.7 3.6
AGEsb
CML(ng/mg) 785 112 217
Total fluorescent AGEs (AU/mg) 63.8 23.1 28.3
AGEs, advanced glycation end products; CML, N e-carboxymethyllysine; HAD, high-
advanced glycation end products diet; LAD, low-advanced glycation end products
diet; SRD, standard rodent diet.
aNutrients were quantified by the Guangdong Province Institute of Animals Feed.
bContent of AGEs was determined based on enzyme-linked immunosorbent assay
using an anti-CML polyclonal antibody12,20 and on fluorospectrophotometry.19
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Figure 1 | Individual daily food intake (a), serum AGEs concentration (b), and renal AGEs levels (c) of 5/6 Nx rats on HAD, LAD, SRD, and
control rats on SRD. Data are expressed as mean7s.d., n¼ 10 in each group at each time point. (b) ANOVA, Po0.001, (c) ANOVA, Po0.001 at
week 5, 9, and 13. *Po0.05 vs SRD; **Po0.001 vs SRD; #Po0.05 vs control.
Table 2 | Serum lipid profile and albumin
N
Total cholesterol
(mmol/l)
Triglycerides
(mmol/l)
Total protein
(g/l)
Albumin
(g/l)
HAD-fed 5/6 Nx rat 10 3.0370.30 1.4270.29 43.672.6 14.171.8
LAD-fed 5/6 Nx rat 10 2.5170.60 1.2570.23 48.273.5 16.372.7
SRD-fed 5/6 Nx rat 10 2.7570.15a 1.3470.20a 47.472.6 15.572.5a
Sham-operated control 10 1.3670.11 0.5070.02 57.673.0 27.171.4
HAD, high-advanced glycation end products diet; LAD, low-advanced glycation end products diet; SRD, standard rodent diet; Nx, nephrectomy; N, number of rats.
Data were mean7s.d. Blood samples were collected at week 13 of the study after overnight fast.
aPo0.05, compared with sham-operated control.
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rats than in SRD-fed animals. Glomerular volume also
increased with time in the remnant kidney and the increment
was higher in HAD-treated animals than in SRD-treated rats.
In contrast, LAD-fed rats showed significant lower weight of
the remnant kidney at week 13 and decreased glomerular
volume from week 9 as compared with SRD-fed animals.
Effect of dietary AGEs on renal tissue damage
Glomerulosclerosis and interstitial fibrosis progressed with
time in 5/6 Nx rats (Figure 2). Compared with SRD-fed rats,
HAD-fed animals showed marked increase of glomerulo-
sclerosis index (Figure 2a) and interstitial fibrosis score
(Figure 2b) from week 5. Animals given LAD showed
significant improvement of glomerulosclerosis and interstitial
fibrosis in the remnant kidney as compared with rats received
SRD. There was a close correlation between serum AGEs
levels and glomerulosclerosis index (r¼ 0.601, Po0.001,
n¼ 90) or interstitial fibrosis score (r¼ 0.696, Po0.001,
n¼ 90) in 5/6 Nx rats (Figure 3a and b).
To determine the glomerulotubular neck sclerosis, 72744
glomeruli were studied per slide. About 6.9–29.5% of the
Table 3 | Body weight, left kidney weight/body weight, and
glomerular volume
Week 5 Week 9 Week 13
BW (g)
HAD-fed 5/6 Nx rat 319.1716.3 374.1718.4 422.2720.5
LAD-fed 5/6 Nx rat 324.1713.6 364.9714.3 420.578.9
SRD-fed 5/6 Nx rat 320.6717.4 376.7726.7 416.7715.3
Sham-operated control 326.1723.9 368.8711.7 418.3712.4
KW/BW (g/kg)
HAD-fed 5/6 Nx rat 4.170.1a 4.670.1a 4.870.1a
LAD-fed 5/6 Nx rat 3.670.2 3.670.1 3.770.1a
SRD-fed 5/6 Nx rat 3.770.4 3.870.1b 4.270.1b
Sham-operated control 3.670.2 3.170.1 3.270.1
Glomerular volume ( 106 mm3)
HAD-fed 5/6 Nx rat 1.8470.01 2.3170.05a 2.5470.07a
LAD-fed 5/6 Nx rat 1.6270.05 1.7070.14a 1.9670.08a
SRD-fed 5/6 Nx rat 1.6970.05 2.070.06b 2.1770.04b
Sham-operated control 1.0270.02 1.0670.02 1.0670.03
BW, body weight; HAD, high-advanced glycation end products diet; KW, kidney
weight; LAD, low-advanced glycation end products diet; Nx, nephrectomy; SRD,
standard rodent diet.
Data are expressed as mean7s.d.
aPo0.05, compared with SRD-fed 5/6 Nx rat.
bPo0.05, compared with Sham-operated control.
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Figure 2 | Glomerulosclerosis index (a), interstitial fibrosis score (b), macrophage infiltration in glomeruli (c), and in interstitium (d) of
5/6 Nx rats on HAD (&), LAD ( ), SRD ( ), and control rats on SRD (’). Data are expressed as mean7s.d., n¼ 10 in each group at each time
point. (a) ANOVA, Po0.01, (b) ANOVA, Po0.01, (c) ANOVA, Po0.05, (d) ANOVA, Po0.001 at week 5, 9, and 13. *Po0.05 vs SRD; **Po0.001 vs
SRD; #Po0.05 vs control.
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glomeruli had identifiable glomerulotubular junctions. The
average internal glomerulotubular junction lumen diameter
was 24.077.5 mm in sham-operated controls, 8.873.6 mm in
5/6 Nx rats fed with HAD, 10.774.0 mm in SRD, and
18.776.7 mm in rats treated with LAD (analysis of variance
(ANOVA), Po0.001; LAD vs HAD, Po0.001; LAD vs SRD,
Po0.001).
There were few ED1-positive cells in normal renal tissue
removed at the time of the surgery and in sham-operated
animals. Macrophage infiltration was evident in both
glomeruli and interstitium of the remnant kidney. From
week 5, the number of infiltrated macrophages was markedly
increased in HAD- vs SRD-fed 5/6 Nx rats. Restriction of
dietary AGEs significantly decreased macrophage infiltration
in the remnant kidney (Figure 2c and d). A close correlation
was found between serum AGEs levels and the number of
ED1-positive cells in both glomeruli (r¼ 0.728, Po0.001,
n¼ 90) and in interstitium (r¼ 0.723, Po0.001, n¼ 90) in
the remnant kidney (Figure 3c and d).
Effect of dietary AGEs on renal function
Subtotal nephrectomy resulted in renal dysfunction, as
evidenced by progressive increase in serum creatinine (Figure
4a) and decline of creatinine clearance (Ccr) (Figure 4c).
Systolic blood pressure (BP) did not change during the first 5
weeks, but progressively rose at latter time points (Figure 4d).
HAD in 5/6 Nx rats significantly worsen renal dysfunction
and proteinuria without altering systolic BP. In contrast,
LAD-treatment significantly retarded renal dysfunction and
decreased proteinuria at week 13 (Figure 4a–d). There was a
close correlation between serum AGEs levels and urinary
protein excretion (r¼ 0.724, Po0.001, n¼ 90) (Figure 4e)
or Ccr (r¼0.342, P¼ 0.001, n¼ 90) (Figure 4f) in the 5/6
Nx rats.
Effect of dietary AGEs on expression of monocyte
chemoattactant protein-1 and transforming growth factor-b1
Immunohistological studies revealed that monocyte chemo-
attactant protein-1 (MCP-1) and transforming growth
factor-b1 (TGF-b1) staining was limited to minimal positive
reaction of tubular cells and negative in glomeruli. Among
5/6 Nx rats, positive staining of MCP-1 (Figure 5) and TGF-
b1 (Figure 6) was observed in both tubulointerstitium and
glomeruli. Compared with SRD-fed 5/6 Nx rats, higher
staining scores were observed in HAD-fed rats and lower
scores were found in LAD-fed animals (Figures 5a and b and
6a and b). Likewise, expression of MCP-1 (Figure 5c) and
TGF-b1 mRNA (Figure 6c) were upregulated in HAD-fed
rats and downregulated in LAD-fed 5/6 Nx rats as compared
with SRD-fed animals.
Uninary MCP-1 (Figure 5d) and TGF-b1 (Figure 6d) were
markedly increased in 5/6 Nx rats as compared with sham-
operated controls. HAD-fed rats showed higher levels of
urinary MCP-1 and TGF-b1 excretion than rats fed with
SRD. Restriction of dietary AGEs significantly decreased
urinary MCP-1 and TGF-b1 levels from week 9 (Figures 5d
and 6d).
Effect of dietary AGEs on renal redox reaction
As shown in Figure 7, thiobarbituric acid reactive substance
(TBARS) and advanced oxidation protein products (AOPPs)
levels in renal cortical homogenates significantly increased in
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Figure 3 | Relationship between serum AGEs levels and glomerulosclerosis index (a), interstitial fibrosis index (b), and
macrophage infiltration in glomeruli (c) and in interstitium (d).
904 Kidney International (2007) 71, 901–911
o r i g i n a l a r t i c l e JX Feng et al.: Dietary AGEs and renal progression
5/6 Nx rats. HAD treatment significantly increased TBARS
levels (Figure 7a) and AOPPs levels (Figure 7b) from week 9.
Glutathione peroxidase (GSHPx) activity decreased markedly
in HAD-fed rats from week 9 as compared with SRD-fed
animals (Figure 7c). At week 13, TBARS and GSHPx activity
tended to restore in SRD-fed 5/6 Nx rats, but sustained in
HAD-fed animals. LAD-treatment significantly decreased
renal TBARS and AOPPs levels and increased GSHPx activity
(Figure 7a–c). There was a close correlation between renal
AGEs levels and renal TBARS (r¼ 0.654, Po0.001, n¼ 90)
(Figure 7d), renal AOPPs (r¼ 0.815, Po0.001, n¼ 90)
(Figure 7e), or renal GSHPx (r¼0.677, Po0.001, n¼ 90)
(Figure 7f).
DISCUSSION
This study demonstrated that prolonged intake of food rich
in AGEs in the remnant kidney model resulted in accelerated
progression of renal damage and that certain aspect of this
pathology were largely prevented by the restriction of dietary
AGEs intake. Such restriction improves renal function, as
evidenced by reduction of proteinuria and decrease of
tubular fibrosis and glomerulosclerosis. It also retarded
decline of renal function without alteration of BP. Although
there is extensive evidence from both animals and clinical
studies showing significant changes in circulating AGEs levels
as a result of dietary AGEs modulation,8,9,17,20 to the best of
our knowledge, this is the first study demonstrating that
restriction of dietary AGEs intake in chronic renal insuffi-
ciency provides renal protection not only on proteinuria, but
also on progression of renal fibrosis and dysfunction.
Consistent with the previous reports,9,17 our results
showed significant increase of serum CML immunoreactivity
in 5/6 Nx rats fed with HAD. CML has been recognized as
marker of glycoxidant burden in vivo19,21 and is thought to
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Figure 4 | Serum creatinine (a), Ccr (b), urinary protein excretion (c), and systolic BP (d) of 5/6 Nx rats on HAD (—’—), LAD (—K—),
SRD (—m—) or control rats on SRD (—.—). The relationship between serum AGEs levels and (e) urinary protein excretion and (f) Ccr.
Data are expressed as mean7s.d., n¼ 10 in each group at each time point. (a) ANOVA, Po0.05, (b) ANOVA, Po0.05, (c) ANOVA, Po0.001 at
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contribute to intracellular oxidative stress and tissue
damage.19 However, the mechanisms by which dietary
glycoxidation products increase serum CML remain to be
investigated, as some studies report that CML may not be
actively absorbed.22,23
Furthermore, we found that increased circulating AGEs
were associated with enhanced burden of AGEs in renal
tissue. Previous studies have demonstrated that approxi-
mately 10% of ingested AGEs enter the circulation, but only
one-third are excreted within 3 days of ingestion.24 Chronic
renal dysfunction or diabetes is associated with impairment
in AGEs excretion.25 Thus, dietary AGEs intake might be an
important contributor to the body AGEs burden, particularly
in renal insufficiency and diabetes. The increase in kidney-
associated AGEs noted in HAD-fed rats can be attributed in
large part to the covalent attachment of the exogenous AGEs
onto to renal tissue through reactive moieties such as
collagen or to the deposition of filtrated degradation
products of AGEs proteins.13
Renal function, as determined by Ccr, significantly
decreased after nephrectomy. However, Ccr decreased by
68% at week 13 in 5/6 Nx rats corresponding to 83%
resection of renal mass, suggesting that compensatory
glomerular hyperfiltration occurred in this model. Support-
ing this notion, glomerular volume in 5/6 Nx rats
significantly increased after renal mass reduction. The
glomerular volume in the remnant kidney was higher in
HAD-fed than SRD-fed rats. In contrast to the other report,17
it was not accompanied by any significant increase in body
weight. Likewise, the protective effects of LAD were also
marked against the glomerular hypertrophy, indicating that
dietary intake of AGEs might be involved in the pathogenesis
of renal mass hypertrophy and remodeling.
It is interesting to note that LAD rats had less extent of
glomeruli hypertrophy and more preserved Ccr. This might
be related to the significant improvement of interstitial
fibrosis in LAD as compared with HAD or SRD. It has
been well established that interstitial fibrosis is a better
predictor for renal impairment than glomerular changes.26
Sclerosis in the glomerulo-tubular neck, which is associated
with interstitial fibrosis, provides an anatomic and
functional link between tubulointerstitial fibrosis and loss
of glomerular function.27 The less sclerosis of glomerulo-
tubular neck seen in LAD fed rats might decrease resistance
to tubular flow, and contribute to more preserved glomerular
filtration rate.
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Our results showed that modulation of diet AGEs content
affected renal mass remodeling associated with renal mass
reduction. The basic nutrients of the three diets and the daily
food intake among the three groups of 5/6 Nx rats were
comparable, and, there was no significant difference in serum
albumin and lipid profile among groups during the study
period, suggesting that the observed effects were not
attributable to differences in nutrition or lipid profiles. AGEs
can inhibit the activity of nitric oxide in previous study.28
However, there is no evidence to support such a mechanism
of action in this study, based on the absence of changes in BP.
A recent in vivo study demonstrated that activity of renin-
angiotensin system is elevated by infusion of AGEs-modified
protein and this is associated with glomerular and tubular
hypertrophy.29 Although not tested, changes in glomerular
volume and kidney weight were found in response to the
modulation of dietary AGEs, suggesting that food-based
AGEs may have the similar effect on renal hypertrophy.
The accelerated renal fibrosis observed in HAD-fed rats
may be mediated at least in part by the induction of renal
oxidative stress and inflammation. Intake of dietary AGEs in
the remnant kidney model significantly enhanced the
oxidative stress in renal tissue, as evidenced by increase of
renal AOPPs, markers of oxidant-induced protein damage,
and increase of TBARS, which reflects the levels of lipid
peroxidation. HAD administration also reduced the activity
of anti-oxidative system in vivo, as demonstrated by decrease
of intrarenal GSHPx activity. Furthermore, intake of dietary
AGEs in rats with renal impairment upregulated proinflam-
matory chemokine, MCP-1. Overexpression of MCP-1 has
been found to be associated with the cellular inflammation
and the myofibroblastic activity in renal parenchyma.30 HAD
treatment also increased expression of TGF-b1, a well-
documented fibrogenic growth factor that plays a major role
in the pathogenesis of renal inflammation and fibrosis.31
More important finding is that HAD associated intrarenal
oxidative stress and proinflammatory reaction can be largely
inhibited by restricted intake of dietary AGEs, suggesting that
food-based glycoxidation products might be potential
inducers of oxidative stress and inflammation in CKD. The
close relationship between renal AGEs and the parameters of
redox and inflammatory reaction provide further evidence
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supporting the notion. Given the fact that AGEs accumula-
tion occurs from early stage of CKD when Ccr remains at
60 ml/min,16 it is plausible to propose that prolonged intake
of food rich in AGEs may increase AGEs accumulation
followed by renal mass reduction and enhanced the intrarenal
oxidative stress and inflammation. Reactive oxygen species
produced during oxidative stress and inflammation can
further increase endogenous AGEs formation through
promoting of glycoxidation.5 This positive feedback loop
could amplify or maintain the imbalance of redox reaction
and inflammation status, and thus accelerate the renal
fibrosis and the progression of CKD. If this hypothesis is
true, restricted intake of food rich in AGEs might ameliorate
the progression of CKD and should be considered as an
intervention in CKD.
In summary, we demonstrated that intake of food rich in
AGEs accelerates renal progression in the remnant kidney
model. Restriction of dietary AGEs intake retards renal
fibrosis and dysfunction, probably via improving renal
oxidative stress and inflammation.
MATERIALS AND METHODS
Rat dietary formulas
The three diets used in this study were purchased from the
Guangdong Province Institute of Animals Feed (Guangzhou,
China). SRD is a rodent diet that is exposed to heat (501C for
15 min) during pelleting and is fortified with supplement to offset
heat-depleted micronutrients. LAD was prepared by SRD without
exposure to heat, and HAD consisted of the same SRD exposed to
the heat cycle (1801C for 30 min). The three dietary formulas were
nutritionally equivalent (Table 1). However, as reported pre-
viously,32 heat procedure increased AGEs content, based on
assessment of enzyme-linked immunosorbent assay using an anti-
CML polyclonal antibody12,18 and on determination of total AGEs
fluorescence by fluorospectrophotometry.19 LAD contained seven-
fold lower level of CML and 2.5-fold lower fluorescent AGEs as
compared with HAD. The diets were kept at 41C.33
Animals and treatment
Male 12-week-old Sprague–Dawley rats (initial weight, 220–240 g,
n¼ 120) were purchased from the Southern Medical University
Animal Experiment Center. Rats were given food and water ad
libitum in a standardized environment at the center for Laboratory
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Animal Science, Nanfang Hospital. The Animal Experiment
Committee of Southern Medical University approved animal care
and experimental procedures. After 1 week of adjustment, the rats
were subjected either to 5/6 Nx (n¼ 90, by performing a right
nephrectomy with surgical resection of the two-thirds of the left
kidney) or to sham operation (controls, n¼ 30). One week after the
operation, the 5/6 Nx rats were randomized by the percent remnant
kidney weight removed ((right kidney weightweight of two poles
of left kidney)/right kidney weight  100), divided into three
subgroups (n¼ 30 in each subgroup), and were fed for indicated
time with the three kinds of diet, respectively. The control rats were
given SRD. To guarantee equal food intake, the food intake were
recorded daily for 1 week.
At the end of 5, 9, and 13 weeks, the rats (n¼ 10 in each time
point) were anesthetized and exsanguinated by an abdominal aortic
puncture. The left kidneys were collected after perfusion with 50 ml
of ice-cold normal saline. The 24-h urine samples were collected in
the metabolic cages before killed.
Assessment of AGEs content
The concentration of AGEs in all specimens was measured by a
competitive enzyme-linked immunosorbent assay using a polyclonal
antibody against CML, as described previously.12,18 The antibody is
highly reactive with soluble and structural proteins modified by
CML, an established biomarker for AGEs.18,19 We also quantitated
fluorescent AGEs in the diet by using fluorospectrometry as
described previously.18 This method detects low molecular mass
AGEs peptides or free adducts such as pentosidine crosslink and
argpyrimidine.34 The content of AGEs determined by the above
methods has been compared with that measured by high-
performance liquid chromatograph and by mass spectrometry.12
Forty-three units/mg of AGEs as measured by fluorospectrometry
were equal to 135 pmol/mg of pentosidine as measured by high-
performance liquid chromatograph and 525 ng/mg of AGEs
measured by enzyme-linked immunosorbent assay were equal to
43.8 nmol/mg of CML as determined by mass spectrometry.12
BP and kidney function
Systemic BP was measure before the rats were killed. A PE-50
catheter was inserted into the femoral artery and BP was determined
by a pressure transducer (Gould, MA, USA) connected to a
physiological recorder (Gilson Medical Electronics, Middleton,
OH, USA).
Twenty-four-hour urinary excretion was measured using the
Coomassie Blue method.35 Creatinine levels in serum and urine
were measured by using a commercial kit (sarcosine oxidase-
peroxidase-antiperoxidase, Zixing, Shanghai, China). Ccr was
calculated and factored for body weight as described previously.36
Renal quantitative morphometry
Renal tissue was embedded in paraffin and sliced in 2 mm-thick
sections. These were stained by periodic acid-Schiff and Masson’s
Trichrome. Morphological analyses were performed by an experi-
enced pathologist blinded to the source of the tissue. The extent of
glomerular sclerosis was assessed as described previously.37 At least
50 glomeruli from each kidney were graded for individual glomeruli
on the periodic acid-Schiff-stained sections according to the
following criteria: 0, no sclerosis; 1, less than 25% cross-sectional
sclerosis; 2, 25–50% exhibiting sclerosis; 3, 50–75% exhibiting
sclerosis; and 4, over 75% cross-sectional sclerosis. The
sclerosis index for each rat was calculated as follow:
(N1 1þN2 2þN3 3þN4 4)/n, where N1, N2, N3, and
N4 represent the numbers of glomeruli exhibiting grades 1, 2, 3, and
4, respectively, and n represents the number of glomeruli assessed.38
Similarly, trichrome-stained sections from each kidney cortex were
graded for the presence of interstitial fibrosis according to the
following scale: 0, no evidence of interstitial fibrosis; 1, less than
25% involvement; 2, 25–50% involvement; and 3, more than 50%
involvement.39 The scale for each rat was reported as the mean of 20
random high-power ( 400) fields per section. The average
glomerular tuft volume was estimated at each time of killing as
described previously.40 The mean glomerular cross-sectional area
(Ag) was determined by averaging approximately 50 glomerular
sections. Individual glomerular volume (Vg) was calculated as
Vg¼ 1.25 (Ag) (3/2).40 Glomerulo-tubular neck diameters were
measured at  400 magnification with a microscope micrometer
(HMIAS-2000, Champion Image, Wuhan, China) as described
previously.27 Five 5-mm serial sections stained by periodic acid-
Schiff were mounted per slide. A total of 20 slides (five slides from
each group) were studied in a masked manner.
Renal immunohistochemical analyses
The immunoperoxidase staining was performed as described
previously,41 with the following antibodies: macrophage infiltration
were detected with monoclonal anti-ED1 (Serotec, Oxford, UK);
TGF-b1 expression was detected with polyclonal rabbit anti-rat
TGF-b1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA); MCP-1
was analyzed with polyclonal rabbit anti-rat MCP-1 (Boster
Biological, Wuhan, China). Control experiments included omission
of the primary antibodies and substitution of the primary antibodies
with nonimmune rabbit or mouse immunoglobulin G.
Macrophage infiltration was quantitated by counting the number
of ED1-positive cells in 30 glomerular profiles and in 20 randomly
chosen 0.25 0.25 mm areas of tubulointerstitium for each
kidney.42
The intensity of glomerular staining of TGF-b1 and MCP-1 was
evaluated under  400 magnification according to the following
scale: 0, no staining; 1, weak and spotty intraglomerular staining; 2,
moderate and segmental intraglomerular staining; and 3, strong and
diffuse (involving more than 50%) intraglomerular staining. Like-
wise, the intensity of tubulointerstitial staining in cortical areas was
assessed under  250 magnification as the following scale: 0, no
staining; 1, less than 25% involvement; 2, 25–50% involvement; and
3, more than 50% involvement. All, but at least 20 glomeruli and 20
randomly selected cortical tubulointerstitial areas from each sample
were evaluated.
Reverse transcriptase-polymerase chain reaction
Total RNA was extracted from renal cortex tissue using RNase mini
kit (Qiagen, Valencia, CA, USA). Primers for MCP-1, TGF-b1, and
glyceraldehydes-phosphate dehydrogenase were designed and
synthesized based on published sequence of these genes.42 The
upstream and downstream of these primers are: (1) MCP-1: 50-GTC
ACC AAG CTC AAG AGA GAG A-30, 50-GAG TGG ATG CAT TAG
CTT CAG A-30; (2) TGF-b1: 50-CTT CAG CTC CAC AGA GAA
GAA CTG C-30, 50-CAC GAT CAT GTT GGA CAA CTG CTC C-30;
(3) glyceraldehydes-phosphate dehydrogenase: 50-AAT GCA TCC
TGC ACC ACC AA-30, 50-GTA GCC ATA TTC ATT GTC ATA-30.
Reverse transcriptase-polymerase chain reaction was performed
using Qiagen One Step reverse transcriptase-polymerase chain
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reaction kit (Qiagen) according to the manufacturer’s instruction.
Polymerase chain reaction products resolved in 2% agarose gels were
photographed under ultraviolet light. Densities of bands were
measured by scanning densitometry with UVIBAND V.99 Software
(UVI, SJ, England). The results were expressed as optical density
ratios relative to control (MCP-1 or TGF-b1: glyceraldehydes-
phosphate dehydrogenase).
Parameters of biochemistry, oxidative stress, and
inflammation
Serum levels of albumin and lipid were analyzed by an automatic
biochemistry analyzer (Olympus AU540, Japan).
Lipid peroxides in the renal cortical homogenate were measured
as TBARS by fluorometric assay.43 GSHPx activity and AOPPs in the
renal tissue were measured as described previously.44,45 Urinary
MCP-1 or TGF-b1 were quantitated by enzyme-linked immuno-
sorbent assay using commercial kits (BioSource, Camarillo, CA,
USA) according to the manufacturer’s instruction.
Statistical analyses
All data are presented as mean7s.d. Main and interactive effect of
AGEs and 5/6 Nx were analyzed by factorial analysis. Serum
creatinine, Ccr, and urinary protein excretion were adjusted by
covariates before intervention. Differences in the variables between
groups were determined by one-way ANOVA followed by LSD
method. Differences in the variables at each time point between 5/6
Nx and sham-operated rats were compared by independent samples
t-test. The relationship between variables was assessed by Pearson
correlation analysis. Statistical analysis was conducted with SPSS
12.0 for Windows. Significance was defined as Pp0.05.
ACKNOWLEDGMENTS
This work was supported by the National Nature Science Foundation
Grant, China (No. 30330300) and National 973 Research Project
(No. 2006CB03904) to Dr Fan Fan Hou. No potential conflict of
interest relevant to this article was reported.
REFERENCES
1. Collins AJ, Couser WG, Dirks JH et al. World kidney day: an idea whose
time has come. Kidney Int 2006; 69: 781–782.
2. Eddy AA. Molecular insights into renal interstitial fibrosis. J Am Soc
Nephrol 1996; 7: 2495–2508.
3. Vlassara H, Palace MR. Diabetes and advanced glycation end products.
J Intern Med 2002; 251: 87–101.
4. Schleicher ED, Wagner E, Nerlich AG. Increased accumulation of the
glycoxidation product N (epsilon)-(carboxymethyl) lysine in human
tissues in diabetes and aging. J Clin Invest 1997; 99: 457–468.
5. Miyata T, Kurokawa K, van Ypersele de Strihou C. Relevance of oxidative
and carbonyl stress to long-term uremic complications. Kidney Int 2000;
76(Suppl): S120–S125.
6. Weiss MF, Erhard P, Kader-Attia FA et al. Mechanisms for the formation of
glycoxidation products in end-stage renal disease. Kidney Int 2000; 57:
2571–2585.
7. Henle T. AGEs in foods: do they play a role in uremia? Kidney Int 2003;
84(Suppl): 145–147.
8. Hofmann SM, Dong HJ, Li Z et al. Improved insulin sensitivity is associated
with restricted intake of dietary glycoxidation products in the db/db
mouse. Diabetes 2002; 51: 2082–2089.
9. Uribarri J, Peppa M, Cai W et al. Restriction of dietary glycotoxins reduces
excessive advanced glycation end products in renal failure patients. J Am
Soc Nephrol 2003; 14: 728–731.
10. Raj DS, Choudhury D, Welbourne TC, Levi M. Advanced glycation end
products: a Nephrologist’s perspective. Am J Kidney Dis 2000; 35:
365–380.
11. Hou FF, Owen Jr WF. Beta 2-microglobulin amyloidosis: role of
monocytes/macrophages. Curr Opin Nephrol Hypertens 2002; 11: 417–421.
12. Hou FF, Miyata T, Boyce J et al. Beta(2)-microglobulin modified with
advanced glycation end products delays monocyte apoptosis. Kidney Int
2001; 59: 990–1002.
13. Vlassara H, Striker LJ, Teichberg S et al. Advanced glycation end products
induce glomerular sclerosis and albuminuria in normal rats. Proc Natl
Acad Sci USA 1994; 91: 11704–11708.
14. Foerster A, Henle T. Glycation in food and metabolic transit of dietary
AGEs (advanced glycation end-products): studies on the urinary excretion
of pyrraline. Biochem Soc Trans 2003; 31: 1383–1385.
15. Faist V, Wenzel E, Randel G. In vitro and in vivo studies on the metabolic
transit of Ne-carboxymethyllysine. Czech J Food Sci 2000; 18: 116–119.
16. Hou FF, Ren H, Owen Jr WF et al. Enhanced expression of receptor for
advanced glycation end products in chronic kidney disease. J Am Soc
Nephrol 2004; 15: 1889–1896.
17. Sˇebekova´ K, Faist V, Hofmann T et al. Effects of a diet rich in advanced
glycation end products in the rat remnant kidney model. Am J Kidney Dis
2003; 41: S48–S51.
18. Hou FF, Boyce J, Chertow GM et al. Aminoguanidine inhibits advanced
glycation end products formation on beta2-microglobulin. J Am Soc
Nephrol 1998; 9: 277–283.
19. Fu MX, Requena JR, Jenkins AJ et al. The advanced glycation end product,
Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation
and glycoxidation reactions. J Biol Chem 1996; 271: 9982–9986.
20. Cai W, Cao QD, Zhu L et al. Oxidative stress-induced carbonyl compounds
from common foods: novel mediators of cellular dysfunction. Mol Med
2002; 8: 337–346.
21. Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products:
a review. Diabetologia 2001; 44: 129–146.
22. Dittrich R, Hoffmann I, Stahl P et al. Concentrations of Nepsilon-
carboxymethyllysine in human breast milk, infant formulas, and urine of
infants. J Agric Food Chem 2006; 54: 6924–6928.
23. Grunwald S, Krause R, Bruch M et al. Transepithelial flux of early and
advanced glycation compounds across Caco-2 cell monolayers and their
interaction with intestinal amino acid and peptide transport systems. Br J
Nutr 2006; 95: 1221–1228.
24. He C, Sabol J, Mitsuhashi T, Vlassara H. Dietary glycotoxins: inhibition of
reactive products by aminoguanidine facilitates renal clearance and
reduces tissue sequestration. Diabetes 1999; 48: 1308–1315.
25. Howard BV, Wylie-Rosett J. Sugar and cardiovascular disease: A statement
for healthcare professionals from the Committee on Nutrition of the
Council on Nutrition, Physical Activity, and Metabolism of the American
Heart Association. Circulation 2002; 106: 523–527.
26. Nath KA. Tubulointerstitial changes as a major determinant in the
progression of renal damage. Am J Kidney Dis 1992; 20: 1–17.
27. Cohen EP, Robbins ME, Whitehouse E, Hopewell JW. Stenosis of the
tubular neck: a possible mechanism for progressive renal failure. J Lab
Clin Med 1997; 129: 567–573.
28. Huang JS, Chuang LY, Guh JY et al. Effect of nitric oxide-cGMP-dependent
protein kinase activation on advanced glycation end-product-induced
proliferation in renal fibroblasts. J Am Soc Nephrol 2005; 16: 2318–2329.
29. Thomas MC, Tikellis C, Burns WM et al. Interactions between renin
angiotensin system and advanced glycation in the kidney. J Am Soc
Nephrol 2005; 16: 2976–2984.
30. Segerer S, Nelson PJ, Schlondorff D. Chemokines, chemokine receptors,
and renal disease: from basic science to pathophysiologic and
therapeutic studies. J Am Soc Nephrol 2000; 11: 152–176.
31. Okuda S, Languino LR, Ruoslahti E, Border WA. Elevated expression of
transforming growth factor-beta and proteoglycan production in
experimental glomerulonephritis. Possible role in expansion of the
mesangial extracellular matrix. J Clin Invest 1990; 86: 453–462.
32. Koschinsky T, He CJ, Mitsuhashi T et al. Orally absorbed reactive glycation
products (glycotoxins): an environmental risk factor in diabetic
nephropathy. Proc Natl Acad Sci USA 1997; 94: 6474–6479.
33. Peppa M, Brem H, Ehrlich P et al. Adverse effects of dietary glycotoxins on
wound healing in genetically diabetic mice. Diabetes 2003; 52:
2805–2813.
34. Wrobel K, Wrobel K, Garay-Sevilla ME et al. Novel analytical approach to
monitoring advanced glycosylation end products in human serum with
on-line spectrophotometric and spectrofluorometric detection in a flow
system. Clin Chem 1997; 43: 1563–1569.
35. Lott JA, Stephan VA, Pritchard Jr KA. Evaluation of the Coomassie
Brilliant Blue G-250 method for urinary protein. Clin Chem 1983; 29:
1946–1950.
36. Levey AS. Clinical evaluation of renal function. In: Greenberg A (ed).
Primer on Kidney Diseases, 2nd edn. Academic Press: San Diego, CA, USA,
1998, pp 20–26.
910 Kidney International (2007) 71, 901–911
o r i g i n a l a r t i c l e JX Feng et al.: Dietary AGEs and renal progression
37. Raij L, Azar S, Keane W. Mesangial immune injury, hypertension,
and progressive glomerular damage in Dahl rats. Kidney Int 1984; 26:
137–143.
38. Miyazaki T, Aoyama I, Ise M et al. An oral sorbent reduces overload of
indoxyl sulphate and gene expression of TGF-beta1 in uraemic rat
kidneys. Nephrol Dial Transplant 2000; 15: 1773–1781.
39. Ots M, Mackenzie HS, Troy JL et al. Effects of combination therapy
with enalapril and losartan on the rate of progression of renal injury
in rats with 5/6 renal mass ablation. J Am Soc Nephrol 1998; 9:
224–230.
40. Badid C, Vincent M, McGregor B et al. Mycophenolate mofetil reduces
myofibroblast infiltration and collagen III deposition in rat remnant
kidney. Kidney Int 2000; 58: 51–61.
41. Taal MW, Chertow GM, Rennke HG et al. Mechanisms underlying
renoprotection during renin-angiotensin system blockade. Am J Physiol
Renal Physiol 2001; 280: F343–F355.
42. Taal MW, Zandi-Nejad K, Weening B et al. Proinflammatory gene
expression and macrophage recruitment in the rat remnant kidney.
Kidney Int 2000; 58: 1664–1676.
43. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma.
Biochem Med 1976; 15: 212–216.
44. Flohe L, Gunzler WA. Assays of glutathione peroxidase. Methods Enzymol
1984; 105: 114–121.
45. Liu SX, Hou FF, Guo ZJ et al. Advanced oxidation protein products
accelerate atherosclerosis through promoting oxidative stress and
inflammation. Arterioscler Thromb Vasc Biol 2006; 26: 1156–1162.
Kidney International (2007) 71, 901–911 911
JX Feng et al.: Dietary AGEs and renal progression o r i g i n a l a r t i c l e
